Page last updated: 2024-11-08

pentylenetetrazole and Benign Frontal Childhood Epilepsy

pentylenetetrazole has been researched along with Benign Frontal Childhood Epilepsy in 1 studies

Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhu, G1
Okada, M1
Yoshida, S1
Ueno, S1
Mori, F1
Takahara, T1
Saito, R1
Miura, Y1
Kishi, A1
Tomiyama, M1
Sato, A1
Kojima, T1
Fukuma, G1
Wakabayashi, K1
Hase, K1
Ohno, H1
Kijima, H1
Takano, Y1
Mitsudome, A1
Kaneko, S1
Hirose, S1

Other Studies

1 other study available for pentylenetetrazole and Benign Frontal Childhood Epilepsy

ArticleYear
Rats harboring S284L Chrna4 mutation show attenuation of synaptic and extrasynaptic GABAergic transmission and exhibit the nocturnal frontal lobe epilepsy phenotype.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008, Nov-19, Volume: 28, Issue:47

    Topics: Age Factors; Analysis of Variance; Animals; Behavior, Animal; Cerebral Cortex; Dose-Response Relatio

2008